First Capital Ventures

B-Secur Ltd. is a Belfast-based company that specializes in ECG biometric technology to enhance digital security. Founded in 1996, the company has developed a distinctive method of user identification by analyzing an individual's unique heartbeat pattern through their fingertips. This innovation moves beyond traditional security measures such as passwords and PINs, offering a more sophisticated approach suitable for various applications, including mobile banking, access control, and health monitoring. B-Secur's patented technology has garnered recognition in the Financial Services sector and has been supported by recent investments to further advance research and development efforts. The team comprises experts from diverse fields, including technology, biometrics, and consumer marketing, all working towards creating innovative solutions that redefine how users interact with technology in a connected world.

KromaTiD, Inc. is an early-stage bioscience company based in Fort Collins, Colorado, established in 2007. The company specializes in chromosome analysis products aimed at advancing the understanding of genetic abnormalities and diseases. KromaTiD develops molecular cytogenetic assays and reagents, including its proprietary Directional Genomic Hybridization (dGH) technology, which enhances standard fluorescence in situ hybridization (FISH) assays. These tools enable researchers to discover, detect, and diagnose various disease-causing mutations, such as inversions and translocations, from single cells. KromaTiD’s offerings include assays for targeting entire chromosomes or individual chromatids, inversion detection solutions, and custom assays covering the entire human genome. Their products are designed to support biomedical research and medical testing applications, facilitating advancements in oncology and rare diseases, and assisting research teams in academia and the biopharma sector in developing novel therapeutics.